BACKGROUND AND OBJECTIVE: The @entity417 Working Group of @entity69826 in 2010 recommended a target hemoglobin (Hb) level in the range of 11-12g/dL, without intentionally exceeding 13g/dL during the treatment with erythropoiesis stimulating agents (ESAs). This study evaluated if there was a clinical impact of this statement in the @entity417 management of @entity740 ( @entity740 ) @entity1 treated with ESAs not on dialysis in routine clinical practice in Spain. METHODS: This was an observational and cross-sectional study carried out in @entity740 @entity1 not on dialysis in Spain who initiated ESA treatment (na  ve), or were shifted from a previous ESA to another ESAs (converted) since January 2011. RESULTS: Of 441 @entity1 evaluated, 67.6% were na  ve and 32.4% were converted. At the study visit, 42.5% of na  ve @entity1 achieved the Hb target of 11-12g/dL, with a mean Hb of 11.3  1.3  g/dL (vs 10.1  0.9g/dL at the start of ESA therapy). Only 35.3% of converted @entity1 maintained Hb levels within the recommended target at the study visit. Yet, 8.2% of na  ve @entity1 and 7.9% of those converted had Hb levels >13g/dL. Hb levels were similar across subgroups of @entity1 , regardless of the presence of significant comorbidities. CONCLUSIONS: @entity417 management in @entity740 @entity1 treated with ESAs by Spanish nephrologists seems to be aimed at preventing Hb levels <11g/dL, while <50% of @entity1 were within the narrow recommended Hb target range. This, together with the lack of individualization in Hb targets according to @entity1 ' comorbidities show that there is still room for improvement in @entity8 management in the clinical setting.

Clinical impact of the @entity69826 Working Group 2010 Recommendations for the XXXX management in @entity740 not on dialysis: ACERCA study.

@entity1 :: ('9606', 'Species') :: ['patients'] @entity8 :: ('MESH:D007674', 'Disease') :: ['renal anemia'] @entity417 :: ('MESH:D000740', 'Disease') :: ['Anemia', 'anemia'] @entity69826 :: ('30836', 'Gene') :: ['ERBP'] @entity740 :: ('MESH:D051436', 'Disease') :: ['CKD', 'chronic kidney disease']
@entity417 :: (MESH:D000740,Disease) :: ['anemia']
